Q3 2024 |
196 |
$4.01B |
+$898M |
-$1.14B |
-$246M |
BACPRL, WFCPRL, APOPRA, NEEPRR, HPEPRC
|
13F-HR |
11/13/2024, 02:01 PM |
Q2 2024 |
179 |
$4.11B |
+$1.28B |
-$1.07B |
+$216M |
BACPRL, WFCPRL, APOPRA, NEEPRR, ALBPRA
|
13F-HR |
8/13/2024, 01:05 PM |
Q1 2024 |
166 |
$3.93B |
+$538M |
-$1.05B |
-$513M |
WFCPRL, BACPRL, NEEPRR, APOPRA, GTLSPRB
|
13F-HR |
5/14/2024, 03:37 PM |
Q4 2023 |
182 |
$4.32B |
+$886M |
-$1.07B |
-$184M |
WFCPRL, BACPRL, NEEPRR, APOPRA, GTLSPRB
|
13F-HR |
2/13/2024, 03:31 PM |
Q3 2023 |
186 |
$4.27B |
+$815M |
-$1.35B |
-$539M |
BACPRL, WFCPRL, NEEPRR, APOPRA, GTLSPRB
|
13F-HR |
11/13/2023, 04:52 PM |
Q2 2023 |
193 |
$4.9B |
+$1.36B |
-$1.74B |
-$377M |
BACPRL, WFCPRL, KKRPRC, NEEPRQ, NIMC
|
13F-HR |
8/11/2023, 02:40 PM |
Q1 2023 |
201 |
$5.21B |
+$691M |
-$1.2B |
-$511M |
BACPRL, WFCPRL, NEEPRQ, NIMC, KKRPRC
|
13F-HR |
5/12/2023, 04:12 PM |
Q4 2022 |
236 |
$5.6B |
+$1.55B |
-$1.54B |
+$14.6M |
BACPRL, WFCPRL, NIMC, NEEPRQ, KKRPRC
|
13F-HR |
2/14/2023, 10:04 AM |
Q3 2022 |
221 |
$5.43B |
+$878M |
-$1.02B |
-$138M |
BACPRL, WFCPRL, NEEPRQ, KKRPRC, NIMC
|
Restatement |
11/14/2022, 09:31 PM |
Q2 2022 |
246 |
$5.65B |
+$1.13B |
-$917M |
+$212M |
BACPRL, WFCPRL, NEEPRQ, KKRPRC, NIMC
|
13F-HR |
8/15/2022, 12:09 PM |
Q1 2022 |
272 |
$6.21B |
+$1.66B |
-$1.17B |
+$497M |
BACPRL, WFCPRL, KKRPRC, NEEPRQ, SWT
|
13F-HR |
5/13/2022, 03:13 PM |
Q4 2021 |
272 |
$5.87B |
+$1.52B |
-$1.07B |
+$454M |
BACPRL, WFCPRL, KKRPRC, SWT, AVGOP
|
13F-HR |
2/14/2022, 12:12 PM |
Q3 2021 |
265 |
$5.41B |
+$1.14B |
-$832M |
+$310M |
SWT, NEEPRQ, AEPPZ, NIMC, NEEPRP
|
13F-HR |
11/15/2021, 12:18 PM |
Q2 2021 |
252 |
$5.14B |
+$1.56B |
-$1.09B |
+$480M |
SWT, NEEPRQ, AEPPZ, NIMC, DCUE
|
13F-HR |
8/16/2021, 01:01 PM |
Q1 2021 |
246 |
$4.64B |
+$927M |
-$1.06B |
-$133M |
SWT, NEEPRQ, DCUE, AEPPZ, NEEPRP
|
13F-HR |
5/17/2021, 02:59 PM |
Q4 2020 |
189 |
$4.69B |
+$893M |
-$1.24B |
-$351M |
SWT, NEEPRQ, DCUE, NEEPRP, DTP
|
13F-HR |
2/16/2021, 01:51 PM |
Q3 2020 |
170 |
$4.53B |
+$692M |
-$718M |
-$26.1M |
BACPRL, WFCPRL, SWT, DCUE, NEEPRP
|
13F-HR |
11/16/2020, 03:03 PM |
Q2 2020 |
164 |
$4.25B |
+$515M |
-$1.36B |
-$844M |
BACPRL, WFCPRL, DCUE, SWT, NEEPRO
|
13F-HR |
8/14/2020, 10:16 AM |
Q1 2020 |
186 |
$4.57B |
+$936M |
-$833M |
+$103M |
BACPRL, WFCPRL, AVGOP, DCUE, NEEPRO
|
13F-HR |
5/15/2020, 02:37 PM |
Q4 2019 |
198 |
$5.16B |
+$567M |
-$1B |
-$435M |
BACPRL, WFCPRL, AVGOP, DCUE, SOLN
|
13F-HR |
2/14/2020, 01:24 PM |
Q3 2019 |
198 |
$5.34B |
+$1.06B |
-$885M |
+$179M |
WFCPRL, BACPRL, SOLN, DCUE, AEPPL
|
13F-HR |
11/14/2019, 03:59 PM |
Q2 2019 |
190 |
$5.17B |
+$1.21B |
-$682M |
+$526M |
WFCPRL, BACPRL, DCUE, NEEPRR, BDXA
|
13F-HR |
8/14/2019, 03:30 PM |
Q1 2019 |
192 |
$4.53B |
+$822M |
-$696M |
+$126M |
WFCPRL, BACPRL, NEEPRR, DHRPRA, SWP
|
13F-HR |
5/15/2019, 12:52 PM |
Q4 2018 |
204 |
$4.13B |
+$544M |
-$849M |
-$305M |
WFCPRL, BACPRL, NEEPRR, BDXA, SWP
|
13F-HR |
2/14/2019, 04:09 PM |
Q3 2018 |
288 |
$4.8B |
+$992M |
-$994M |
-$1.95M |
WFCPRL, BACPRL, SWP, BDXA, CCIPRA
|
13F-HR |
11/14/2018, 05:17 PM |
Q2 2018 |
236 |
$4.71B |
+$650M |
-$1.02B |
-$373M |
WFCPRL, BACPRL, SWP, BDXA, NEEPRR
|
13F-HR |
8/14/2018, 01:32 PM |
Q1 2018 |
247 |
$5.02B |
+$1.03B |
-$1.14B |
-$112M |
WFCPRL, BACPRL, SWP, BDXA, NEEPRR
|
13F-HR |
5/11/2018, 01:43 PM |
Q4 2017 |
229 |
$5.22B |
+$767M |
-$888M |
-$121M |
WFCPRL, BACPRL, BDXA, SWP, NEEPRR
|
13F-HR |
2/13/2018, 12:29 PM |
Q3 2017 |
241 |
$5.28B |
+$763M |
-$839M |
-$76.3M |
WFCPRL, BACPRL, BDXA, CCIPRA, AGNPRA
|
13F-HR |
11/14/2017, 11:07 AM |
Q2 2017 |
254 |
$5.19B |
+$694M |
-$905M |
-$211M |
WFCPRL, BACPRL, BDXA, AGNPRA, SWP
|
13F-HR |
8/9/2017, 11:04 AM |
Q1 2017 |
223 |
$5.34B |
+$578M |
-$872M |
-$294M |
WFCPRL, ANTX, BACPRL, NEEPRR, DCUD
|
13F-HR |
5/5/2017, 10:33 AM |
Q4 2016 |
231 |
$5.43B |
+$690M |
-$2.14B |
-$1.45B |
WFCPRL, ANTX, BACPRL, KEYPRG, FTRPR
|
13F-HR |
2/13/2017, 12:24 PM |
Q3 2016 |
435 |
$6.88B |
+$1.24B |
-$4.25B |
-$3.01B |
WFCPRL, AATRL, BACPRL, ANTX, AREPRD
|
13F-HR |
11/22/2016, 10:35 AM |
Q2 2016 |
401 |
$6.46B |
+$1.22B |
-$1.38B |
-$156M |
WFCPRL, AATRL, BACPRL, ANTX, FTRPR
|
13F-HR |
8/5/2016, 01:06 PM |
Q1 2016 |
372 |
$6.55B |
+$1.24B |
-$1.1B |
+$142M |
WFCPRL, AATRL, BACPRL, ANTX, AREPRD
|
13F-HR |
5/13/2016, 01:50 PM |
Q4 2015 |
396 |
$6.49B |
+$1.09B |
-$1.21B |
-$126M |
WFCPRL, AATRL, FTRPR, ANTX, BACPRL
|
13F-HR |
2/16/2016, 09:30 AM |
Q3 2015 |
434 |
$6.54B |
+$1.22B |
-$1.26B |
-$39.9M |
WFCPRL, AATRL, FTRPR, ANTX, BACPRL
|
13F-HR |
11/13/2015, 12:53 PM |
Q2 2015 |
445 |
$6.95B |
$0 |
$0 |
|
WFCPRL, AATRL, FTRPR, ANTX, BACPRL
|
13F-HR |
7/24/2015, 02:02 PM |
Q1 2015 |
417 |
$6.92B |
+$1.99B |
-$2.03B |
-$47.3M |
WFCPRL, AATRL, BACPRL, AREPRD, TYFDL
|
13F-HR |
5/13/2015, 01:40 PM |
Q4 2014 |
428 |
$6.8B |
+$2.56B |
-$2.22B |
+$348M |
WFCPRL, BACPRL, UTXPRA, TYFDL, AREPRD
|
13F-HR |
2/26/2015, 12:00 PM |
Q3 2014 |
444 |
$6.43B |
+$279M |
-$385M |
-$106M |
UTXPRA, BACPRL, WFCPRL, AREPRD, KEYPRG
|
13F-HR |
11/14/2014, 01:03 PM |
Q2 2014 |
446 |
$6.45B |
+$2.61B |
-$2.2B |
+$402M |
UTXPRA, BACPRL, WFCPRL, AREPRD, KEYPRG
|
Restatement |
9/25/2014, 03:17 PM |
Q1 2014 |
444 |
$6.3B |
+$1.87B |
-$3.46B |
-$1.59B |
UTXPRA, MLU, AREPRD, KEYPRG, AATRL
|
13F-HR |
5/16/2014, 12:06 PM |
Q4 2013 |
600 |
$7.94B |
$0 |
$0 |
|
WFCPRL, UTXPRA, AATRL, KEYPRG, BACPRL
|
13F-HR |
2/11/2014, 10:38 AM |